The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

ADTA     1,3,4-thiadiazol-2-amine

Synonyms: ATDA, A-TDA, PubChem8411, SureCN26211, NSC-4728, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Aminothiadiazole


High impact information on Aminothiadiazole


Chemical compound and disease context of Aminothiadiazole


Anatomical context of Aminothiadiazole


Analytical, diagnostic and therapeutic context of Aminothiadiazole


  1. Effects of 2-amino-1,3,4-thiadiazole on ribonucleotide pools of leukemia L1210 cells. Nelson, J.A., Rose, L.M., Bennett, L.L. Cancer Res. (1976) [Pubmed]
  2. High-dose aminothiadiazole in advanced colorectal cancer. An Illinois Cancer Center phase II trial. Locker, G.Y., Kilton, L., Khandekar, J.D., Lad, T.E., Knop, R.H., Albain, K., Blough, R., French, S., Benson, A.B. Investigational new drugs. (1994) [Pubmed]
  3. Phase II trials of 5-day vinblastine infusion (NSC 49842), L-alanosine (NSC 153353), acivicin (NSC 163501), and aminothiadiazole (NSC 4728) in patients with recurrent or metastatic renal cell carcinoma. Elson, P.J., Kvols, L.K., Vogl, S.E., Glover, D.J., Hahn, R.G., Trump, D.L., Carbone, P.P., Earle, J.D., Davis, T.E. Investigational new drugs. (1988) [Pubmed]
  4. Aminothiadiazole (NSC 4728) in patients with advanced ovarian carcinoma. A phase II study of the Gynecologic Oncology Group. Asbury, R.F., Wilson, J., Blessing, J.A., Buchsbaum, H.J., DiSaia, P.J. Am. J. Clin. Oncol. (1986) [Pubmed]
  5. Mechanism of action of 2-amino-1,3,4-thiadiazole (NSC 4728). Nelson, J.A., Rose, L.M., Bennett, L.L. Cancer Res. (1977) [Pubmed]
  6. Studies of 7 beta-[2-(aminoaryl)acetamido]-cephalosporin derivatives. III. Synthesis and structure-activity relationships in the aminothiadiazole series. Goto, J., Sakane, K., Teraji, T. J. Antibiot. (1984) [Pubmed]
  7. The effect of aminothiadiazole on glycogenesis and glycogenolysis in fetal and neonatal rat liver. Beaudoin, A.R. Teratology (1983) [Pubmed]
  8. Aminothiadiazole (NSC 4728) in patients with advanced carcinoma of the endometrium. A phase II study of the Gynecologic Oncology group. Asbury, R.F., Blessing, J.A., McGuire, W.P., Hanjani, P., Mortel, R. Am. J. Clin. Oncol. (1990) [Pubmed]
  9. A phase II trail of aminothiadiazole in patients with mixed mesodermal tumors of the uterine corpus: a Gynecologic Oncology Group study. Asbury, R., Blessing, J.A., Moore, D. Am. J. Clin. Oncol. (1996) [Pubmed]
  10. Phase II study of aminothiadiazole in advanced squamous cell carcinoma of the esophagus. Engstrom, P.F., Ryan, L.M., Falkson, G., Haller, D.G. Am. J. Clin. Oncol. (1991) [Pubmed]
  11. Aminothiadiazole (NSC 4728) in patients with advanced nonsquamous carcinoma of the cervix. A phase II study of the Gynecologic Oncology Group. Asbury, R.F., Blessing, J.A., DiSaia, P.J., Malfetano, J. Am. J. Clin. Oncol. (1989) [Pubmed]
WikiGenes - Universities